Noticias y eventos de LeonaBio Inc (LONA)

$7.940

+0.050 (+0.63%)Al cierre

Noticias de LONA

8.508-12Newsfilter

LeonaBio to Present Lasofoxifene at Breast Cancer Summit

9.505-07seekingalpha

Athira Pharma Q1 Earnings Beat Expectations

9.505-07seekingalpha

Athira Pharma Q1 Earnings Beat Expectations

5.005-07Newsfilter

LeonaBio Appoints New Board Members to Drive Growth

9.503-27seekingalpha

LeonaBio Reports FY 2025 Financial Results

8.503-26Newsfilter

LeonaBio Secures License for Lasofoxifene Development Program

9.003-26moomoo

LEONABIO INC ANTICIPATES COMPLETION OF PHASE 3 LASOFOXIFENE TRIAL ENROLLMENT BY Q4 2026, WITH TOPLINE RESULTS EXPECTED IN SECOND HALF OF 2027

4.002-19moomoo

LEONABIO INC: MIZUHO UPGRADES RATING TO OUTPERFORM AND INCREASES TARGET PRICE TO $10 FROM $4

Ver más noticias

Eventos de LONA

2/3 07:10

LeonaBio Appoints Mark Kubik as Chief Business Officer

LeonaBio announced the appointment of Mark Kubik as Chief Business Officer. Kubik previously served as a strategic consultant to LeonaBio.

1/20 16:50

LeonaBio Files to Sell 5.5M Shares of Common Stock

LeonaBio files to sell 5.5M shares of common stock for holders

Ver más eventos

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.